US Stock MarketDetailed Quotes

CLDI Calidi Biotherapeutics

Watchlist
  • 1.360
  • -0.090-6.21%
Close Dec 20 16:00 ET
  • 1.470
  • +0.110+8.09%
Post 20:01 ET
26.27MMarket Cap-0.45P/E (TTM)

Calidi Biotherapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 30, 2024

Based on 1 analysts giving stock ratings to Calidi Biotherapeutics in the past 3 months

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Nov 30, 2024

The average Calidi Biotherapeutics stock price target is 2.50 with a max estimate of 2.50 and a min estimate of 2.50

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Nov 30, 2024